Venky's Q4FY26 Net Profit Surges to ₹101.37 Cr; Earnings Call Audio Released

Venky's (India) Limited delivered a strong financial performance for the quarter and year ended 31st March, 2026, with the Board of Directors approving the audited results at their meeting held on 14th May, 2026. The company reported a significant improvement in profitability during the quarter and the full year, driven by improved realizations and operational efficiency across its three business segments. The Board also recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, subject to shareholder approval at the ensuing Annual General Meeting. Subsequently, the company conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026, and filed the audio recording of the call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Highlights

Revenue from operations for Q4FY26 stood at ₹1,100.47 Cr, compared to ₹843.16 Cr in Q4FY25. Profit After Tax for the quarter surged to ₹101.37 Cr from ₹13.30 Cr in the corresponding period of the previous year. For the full year FY26, the company reported a revenue of ₹3,727.32 Cr and a net profit of ₹139.25 Cr. EBITDA for Q4FY26 stood at ₹1.3B versus ₹254M in Q4FY25, with the EBITDA margin expanding significantly to 11.8% from 3.01% in the same period last year.

The following table summarises the key financial metrics for the quarter and full year:

Metric: Q4FY26 Q3FY26 Q4FY25 FY26 FY25 Revenue from Operations (₹ Lakhs): 1,10,047 96,015 84,316 3,72,732 3,30,699 Total Income (₹ Lakhs): 1,11,620 96,998 85,504 3,77,493 3,35,117 Total Expenses (₹ Lakhs): 98,348 90,384 83,205 3,58,938 3,18,846 Profit Before Tax (₹ Lakhs): 13,272 6,614 2,299 18,555 16,271 Net Profit (₹ Lakhs): 10,137 4,858 1,330 13,925 11,662 Basic EPS (₹): 71.96 34.48 9.44 98.85 82.78

Segment Performance

All three business segments of the company registered an improvement in performance during the quarter ended 31st March, 2026. The Poultry and Poultry Products segment benefited from improved realizations from the sale of day-old chicks and grow-up birds. The Animal Health Products segment continued to post good results driven by a better product mix and focus on quality. The Oilseed segment saw a significant turnaround owing to higher capacity utilization and its ability to deliver high-quality products in a competitive environment.

The segment-wise revenue and profitability are detailed below:

Segment: Q4FY26 Revenue (₹ Lakhs) Q4FY25 Revenue (₹ Lakhs) FY26 Revenue (₹ Lakhs) FY25 Revenue (₹ Lakhs) Poultry and Poultry Products: 55,236 47,124 1,89,675 1,92,796 Animal Health Products: 10,595 8,750 39,164 33,931 Oilseed: 47,651 30,741 1,55,414 1,14,075 Total (before inter-segment): 1,13,482 86,615 3,84,253 3,40,802

Segment: Q4FY26 PBT (₹ Lakhs) Q4FY25 PBT (₹ Lakhs) FY26 PBT (₹ Lakhs) FY25 PBT (₹ Lakhs) Poultry and Poultry Products: 8,079 412 6,546 9,951 Animal Health Products: 3,113 1,777 9,899 7,235 Oilseed: 2,518 574 5,438 1,914 Total Segment PBT: 13,710 2,763 21,883 19,100

Balance Sheet & Cash Flow

As at 31st March, 2026, total assets stood at ₹2,30,866 lakhs, up from ₹2,07,033 lakhs as at 31st March, 2025. Total equity increased to ₹1,59,609 lakhs from ₹1,47,558 lakhs. Cash and cash equivalents at the end of the year stood at ₹6,216 lakhs, up from ₹1,488 lakhs at the beginning of the year. Net cash generated by operating activities for the year ended 31st March, 2026 was ₹19,132 lakhs, compared to ₹6,620 lakhs in the previous year.

Key balance sheet items are summarised below:

Particulars: 31 Mar 2026 (₹ Lakhs) 31 Mar 2025 (₹ Lakhs) Total Assets: 2,30,866 2,07,033 Total Equity: 1,59,609 1,47,558 Total Non-Current Liabilities: 7,397 6,422 Total Current Liabilities: 63,860 53,053 Cash and Cash Equivalents: 6,216 1,488 Inventories: 32,901 24,788 Trade Receivables: 54,404 55,381

Dividend Declaration

The Board has recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dividend, if approved by shareholders, will be paid within the statutory time limit following the ensuing Annual General Meeting.

Earnings Call Audio Recording

Venky's (India) Limited conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026. The company filed the audio recording of the investor call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was made by Rohan Bhagwat, Company Secretary & Compliance Officer.

Venky's (India) Limited delivered robust financial performance in Q3FY26, with net profit surging 138.32% year-on-year to ₹4,858 lakhs. The poultry major's strong operational execution and improved market realisations drove the impressive growth trajectory during the quarter ended December 31, 2025.

Financial Performance Overview

The company's revenue from operations increased 7.76% to ₹95,015 lakhs in Q3FY26 compared to ₹88,161 lakhs in Q3FY25. Total income, including other income, reached ₹96,998 lakhs against ₹81,123 lakhs in the previous quarter and ₹89,340 lakhs in Q3FY25.

Financial Metric: Q3FY26 Q3FY25 Change (%) Revenue from Operations: ₹95,015 lakhs ₹88,161 lakhs +7.76% Total Income: ₹96,998 lakhs ₹89,340 lakhs +8.57% Net Profit: ₹4,858 lakhs ₹2,038 lakhs +138.32% Earnings Per Share (Basic): ₹34.48 ₹14.47 +138.29%

Segment-wise Performance

The poultry and poultry products segment emerged as the primary growth driver, benefiting from improved realisations in day-old chicks and grown-up birds sales. The segment reported revenue of ₹49,123 lakhs in Q3FY26. Animal health products contributed ₹8,798 lakhs, while the oilseed segment generated ₹32,577 lakhs in revenue.

Business Segment: Q3FY26 Revenue Segment Result Poultry and Poultry Products: ₹49,123 lakhs ₹4,864 lakhs Animal Health Products: ₹8,798 lakhs ₹2,347 lakhs Oilseed: ₹32,577 lakhs ₹897 lakhs

Nine-Month Performance

For the nine-month period ended December 31, 2025, Venky's reported revenue from operations of ₹2,62,685 lakhs compared to ₹2,46,383 lakhs in the corresponding period last year. Net profit for the nine-month period stood at ₹10,332 lakhs, reflecting the company's consistent operational performance across segments.

Operational Highlights

Total expenses for Q3FY26 were ₹90,384 lakhs, with cost of materials consumed being the largest component at ₹60,807 lakhs. Employee benefits expense increased to ₹6,424 lakhs, while other expenses totaled ₹11,758 lakhs. The company maintained disciplined cost management while scaling operations.

Corporate Developments and Regulatory Compliance

The Board of Directors approved these audited financial results in their meeting held on February 9, 2026, which commenced at 10:30 AM IST and concluded at 1:30 PM IST. The results were reviewed by the Audit Committee before board approval and subsequently submitted to statutory auditors for their audit report.

The company has submitted its quarterly results to both the National Stock Exchange of India Limited (scrip code: VENKEYS) and Bombay Stock Exchange Limited (scrip code: 523261) under Regulation 33. Company Secretary and Compliance Officer Rohan Bhagwat signed the regulatory filings on February 9, 2026.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.